Long-running efforts to limit health plans' ability to deny or delay physician-ordered care are on hold again, despite ...
Two Trump administration regulatory rollbacks affect nursing home staffing and homecare workers, and a new AI experiment in Medicare has alarmed eldercare advocates and congressional Democrats.
The standard Medicare Part B premium has jumped to $202.90 for 2026 from $185 last year. The annual deductible for Medicare ...
Q4 2025 earnings: margin pressure drivers, margin recovery plan, and GARP valuation (15.9% EPS CAGR, 1x PEG). Read more here.
Illinois, along with 17 other states, is opposing the proposed ending of nursing home minimum staffing standards by the ...
Late last year, the Centers for Medicare and Medicaid repealed parts of the Biden Administration’s nursing home staffing ...
State officials say the president’s actions are a new form of retribution, even as the White House has pardoned allies ...
The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...
Affordable Care Act (ACA) enrollment dropped by more than a million after enhanced subsidies expired last year, causing monthly insurance premiums to skyrocket. The Centers for Medicare and ...
The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...
The drugs up for price negotiations include cancer and diabetes drugs, as well as medications for Crohn's disease, ulcerative colitis and rheumatoid arthritis.
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis treatment Xeljanz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results